Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1541 |
|---|---|
| Identifier | NCT03006068 |
| Trial Title | A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Upadacitinib (ABT-494)|DRUG: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Mobile |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2017-01-31 |
|---|---|
| Primary Completion Date | 2025-07-27 |
| Completion Date | 2025-07-27 |